PRESS RELEASE published on 06/04/2024 at 18:36, 5 months 16 days ago Original-Research: Vita 34 AG (von Montega AG): Halten Vita 34 AG steigert Umsatz in Q1 um 3,6% auf 18,6 Mio. EUR. Montega AG empfiehlt Halten mit Kursziel 6,00 EUR. Analyse von Tim Kruse (CFA). Lizenzverfahren CAR-T bleibt offen Montega AG Vita 34 AG Umsatzsteigerung Halten Lizenzverfahren CAR-T
BRIEF published on 05/31/2024 at 08:38, 5 months 21 days ago Vita 34 annonce des augmentations significatives de ses bénéfices et de ses flux de trésorerie Hausse Des Revenus BAIIA Résultats Du Premier Trimestre 2024 Vie 34 Flux De Trésorerie Opérationnel
BRIEF published on 05/31/2024 at 08:38, 5 months 21 days ago Vita 34 Reports Significant Increases in Earnings and Cash Flow EBITDA Revenue Growth Operating Cash Flow Q1 2024 Earnings Vita 34
PRESS RELEASE published on 05/31/2024 at 08:33, 5 months 21 days ago Vita 34 significantly increases earnings and operating cash flow in the first quarter Vita 34 AG reports a significant increase in earnings and operating cash flow in the first quarter of 2024, with revenues up by 3.6% to EUR 18.6 million. EBITDA exceeds EUR 1.5 million Revenues Business Development Earnings Operating Cash Flow Vita 34 AG
BRIEF published on 04/30/2024 at 22:56, 6 months 20 days ago Vita 34 Sees Financial Growth and Improvement in 2023 Investment Strategies 2024 Outlook Vita 34 AG Financial Growth Increase In EBITDA
BRIEF published on 04/30/2024 at 22:56, 6 months 20 days ago Vita 34 connaît une croissance et une amélioration financières en 2023 Croissance Financière Perspectives 2024 Vita 34 AG Stratégies D'investissement Augmentation De L'EBITDA
PRESS RELEASE published on 04/30/2024 at 22:51, 6 months 20 days ago Vita 34 returns to growth path in 2023 Vita 34 AG reports 11.8% revenue growth to EUR 77.1 million in 2023 despite challenging environment. EBITDA significantly improved to EUR 5.6 million EBITDA Revenue Growth Business Development Vita 34 AG Cell Bank
BRIEF published on 04/19/2024 at 12:33, 7 months 2 days ago Vita 34 obtient des résultats financiers meilleurs que prévu pour 2023 Performance Financière Vita 34 AG Hausse Des Revenus BAIIA Rapport Sur Les Revenus
BRIEF published on 04/19/2024 at 12:33, 7 months 2 days ago Vita 34 Achieves Better Than Expected Financial Results for 2023 EBITDA Revenue Growth Financial Performance Earnings Report Vita 34 AG
PRESS RELEASE published on 04/19/2024 at 12:28, 7 months 2 days ago EQS-Adhoc: Vita 34 closes 2023 with significantly better results than expected based on preliminary figures Vita 34 AG exceeds 2023 earnings expectations with EUR 5.6 million EBITDA, forecasts revenues of EUR 81-88 million and EBITDA of EUR 6.5-8.0 million for 2024 Revenues EBITDA Forecast Earnings Vita 34 AG
Published on 11/21/2024 at 13:00, 16 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 16 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 16 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 16 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 16 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 40 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 1 minute ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 46 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 06:58, 6 hours 18 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 18 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 18 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 17 hours 8 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 56 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
